|
Volumn 20, Issue 1 Supplement, 1992, Pages
|
Immunological effects of cefodizime in patients undergoing antineoplastic chemotherapy
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BLEOMYCIN;
CD4 ANTIGEN;
CD8 ANTIGEN;
CEFODIZIME;
CEPHALOSPORIN;
CISPLATIN;
ETOPOSIDE;
ADULT;
B LYMPHOCYTE;
CANCER CHEMOTHERAPY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED STUDY;
DRUG EFFECT;
ERYTHROCYTE COUNT;
HAIR LOSS;
HELPER CELL;
HUMAN;
HUMAN CELL;
IMMUNE RESPONSE;
INTRAVENOUS DRUG ADMINISTRATION;
LEUKOCYTE COUNT;
LYMPHOCYTE DIFFERENTIATION;
LYMPHOCYTE PROLIFERATION;
LYMPHOCYTE SUBPOPULATION;
LYMPHOCYTE TRANSFORMATION TEST;
MALE;
NAUSEA;
NORMAL HUMAN;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SUPPRESSOR CELL;
TESTIS CANCER;
THROMBOCYTE COUNT;
VOMITING;
ADOLESCENT;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BIOLOGICAL RESPONSE MODIFIERS;
CD4-CD8 RATIO;
CEFOTAXIME;
HUMAN;
LYMPHOCYTE ACTIVATION;
MALE;
MIDDLE AGE;
T-LYMPHOCYTES;
TESTICULAR NEOPLASMS;
|
EID: 0026670239
PISSN: 03008126
EISSN: 14390973
Source Type: Journal
DOI: 10.1007/BF01709958 Document Type: Article |
Times cited : (5)
|
References (10)
|